Related News
Abbott says China market not affected by recall
Source: Shanghai Daily |
September 23, 2010, Thursday
|
Online Edition
Online Edition
A spokesman at Abbott Nutrition International said yesterday in Chicago that its voluntary recall of certain Similac brand powder infant formulas did not affect China market.
Steven B. Collens, director and head of public affairs at Abbott Nutrition International, told Xinhua in a telephone interview: "Consumers in China should be assured that no products distributed locally by Abbott Nutrition are affected by the recent proactive, voluntary recall of some Abbott Nutrition products in the United States, Puerto Rico, Guam and some countries in the Caribbean."
Collens further explained that Abbott initiated this recall due to a situation that was isolated to one production area in a single manufacturing facility in the United States. Abbott is recalling these products following an internal quality review.
The recall of these powder infant formulas includes: Certain Similac powder product lines offered in plastic containers and certain Similac powder product lines offered in sizes such as 8-ounce, 12.4-ounce and 12.9-ounce cans. No Abbott liquid infant formulas are impacted.
The company is implementing a plan to address this matter in the affected manufacturing facility, which is expected to be completed shortly. No other facilities or products are involved in this recall. Abbott has consulted with the US FDA regarding this recall.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
Steven B. Collens, director and head of public affairs at Abbott Nutrition International, told Xinhua in a telephone interview: "Consumers in China should be assured that no products distributed locally by Abbott Nutrition are affected by the recent proactive, voluntary recall of some Abbott Nutrition products in the United States, Puerto Rico, Guam and some countries in the Caribbean."
Collens further explained that Abbott initiated this recall due to a situation that was isolated to one production area in a single manufacturing facility in the United States. Abbott is recalling these products following an internal quality review.
The recall of these powder infant formulas includes: Certain Similac powder product lines offered in plastic containers and certain Similac powder product lines offered in sizes such as 8-ounce, 12.4-ounce and 12.9-ounce cans. No Abbott liquid infant formulas are impacted.
The company is implementing a plan to address this matter in the affected manufacturing facility, which is expected to be completed shortly. No other facilities or products are involved in this recall. Abbott has consulted with the US FDA regarding this recall.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
